Summary
The haemodynamic and electrocardiographic effects of amiodarone, diltiazem, and glyceryl trinitrate (nitroglycerin) were compared in an open study of 18 patients with stable exertional angina using a graded treadmill exercise test, Amiodarone and diltiazem exerted similar antianginal effectiveness as assessed by increases in exercise performance and duration of exercise, as well as decreases in ST-segment depression, The antianginal efficacy of glyceryl trinitrate was somewhat lower than that of the other 2 agents, All the drugs were well tolerated
Similar content being viewed by others
References
De Backer G, and Vincke J,: Double blind comparison of diltiazem and placebo in the treatment of exercise inducible chronic stable angina pectoris, Acta Cardiologica 37: 245–255 (1982)
Cote P,; Bourassa M,G,; Délaye J,: Janin A,; Froment R, and David P,: Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease, Circulation 59: 1165–1172 (1979)
Go Jr M, and Hollenberg M,: Improved efficacy of high-dose versus medium and low-dose diltiazem therapy for chronic stable angina pectoris, American Journal of Cardiology 53: 669–673 (1984)
Holt D,W,; Tucker G,T,; Jackson P,R, and Storey G,C,A,: Amiodarone pharmacokinetics, American Heart Journal 106: 840–846 (1983)
Lindenberg B,S,; Weiner D,A,; McCabe C,H,; Cutler S,S,; Ryan T,J, and Klein M,D,: Efficacy and safety of incremental doses of diltiazem for the treatment of stable angina pectoris, Journal of the American College of Cardiology 2: 1120–1133 (1983)
Needleman, P, and Johnson Jr E,M,: Vasodilators and the treatment of angina; in Gilman et al, (Eds) The Pharmacological Basis of Therapeutics, 6th ed,, pp,819–833 (MacMillan, New York 1980)
Polster P, and Broekhuysen J,: The adrenergic antagonism of amiodarone, Biochemical Pharmacology 25: 131–134 (1976)
Rosenbaum M,B,; Chiale P,A,; Haedo A,; Lazzari J,O, and Elizari M,U,: Ten years of experience with amiodarone, American Heart Journal 106: 957–964 (1983)
Rosenthal S,J,; Lamb I,H,; Schroeder J,S, and Ginsburg R,; Long term efficacy of diltiazem for control of symptoms of coronary artery spasm, Circulation Research 52 (Suppl, I): 153–157 (1983)
Schroeder J,S,; Feldman R,L,; Giles T,D,; Friedman M,J,; De Maria A,N,; Kinney E,L,; Mallon S,M,; Pitt B,; Meyer R,; Basta L,L,; Curry Jr R,C,; Groves B,M, and MacAlpin R,N,: Multiclinic controlled trial of diltiazem for Prinzmetal’s angina, American Journal of Medicine 72: 227–232 (1982)
Stone PH,; Amman E,M,; Muller J,E, and Braunwald E,: Calcium channel blocking agents in the treatment of cardiovascular disorders, Part II: Haemodynamic effects and clinical applications, Annals of Internal Medicine 93: 886–904 (1980)
Author information
Authors and Affiliations
Additional information
Amiodarone is marketed by Sanofi Labaz under the trademarks Cordarone (France), Cordarex (Germany), Cordarone-X (UK), Trangorex (Spain), Amiodar (Italy)
Rights and permissions
About this article
Cite this article
Lesbre, J.P., Eloy, J.P. An Open Comparison of Amiodarone with Diltiazem and Glyceryl Trinitrate in Patients with Stable Exertional Angina. Molecular Diagnosis 29 (Suppl 3), 31–36 (1985). https://doi.org/10.2165/00003495-198500293-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198500293-00005